Linde Q3 2026 adjusted EPS rises 9% despite headline declines

What happened

Linde's Q3 2026 net income fell 12% to $1.69B and diluted EPS declined 11% to $3.66 due to purchase accounting and restructuring charges, but adjusted net income grew 7% to $2.12B and adjusted diluted EPS rose 9% to $4.59 on 9% higher sales of $9.40B. The adjusted results indicate that pricing and productivity initiatives continued to offset known headwinds such as helium pricing and soft base volumes, consistent with the company's operating model. The release does not provide updates on key watch items from our prior report, including the Brownsville ASU startup and the magnitude of helium pressure. The strong adjusted EPS growth suggests execution on the 2026 project startup plan and restructuring benefits may be ahead of the conservative base case. However, without explicit management commentary, the risk of a setback remains.

Implication

Investors should monitor the upcoming earnings call for management commentary on helium pricing trends and project startup cadence. If management reiterates the $2.5–$3.0B starting contribution and signals helium pressure easing, the stock could re-rate toward the bull case value of $585. Conversely, if helium remains a persistent drag or startups slip, the current premium valuation (33x P/E) may cap upside and justify a continued wait for a better entry point.

Thesis delta

The Q3 result shifts the thesis slightly more positive, as adjusted EPS growth of 9% validates the pricing and productivity engine despite known headwinds. However, the master report's WAIT rating hinged on specific checkpoints—Brownsville startup, helium trend, and guidance—which remain unconfirmed in this release. Therefore, while the risk-reward has improved, we maintain a cautious stance until management provides explicit updates on those items.